Zdrowie i gospodarka · 18/06/1998

FDA Reopens Comment Period for Draft Guidance on Electronic Regulatory Submissions

The Food and Drug Administration (FDA) is extending the comment period for a draft guidance on electronic submissions for New Drug Applications (NDAs) until July 8, 1998, in response to a request for an extension and to allow additional time for review and comment submission.